We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein Target

News   Jul 18, 2018 | Original story from the University of Adelaide

 
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein Target

A graphical representation of the new molecule (yellow sticks) interacting with 'the sliding clamp' (green surface). Credit: University of Adelaide

 
 
Advertisement
 

RELATED ARTICLES

Compounds Pave Way to Possible Type 1 Diabetes Treatment

News

Researchers have identified two classes of compounds that prevent most of the effects of interferon-α (IFNα) on human beta cells, paving the way for potential future clinical trials of treatments for Type 1 diabetes (T1D).

READ MORE

How A Protein Can Inhibit Cancer Development in Mice

News

Researchers have discovered how the protein PP2A can inhibit tumor growth in mice.

READ MORE

Trial Investigates Remdesivir–Baricitinib Combo as COVID-19 Treatment

News

Following on from remdesivir’s promising results from previous studies, a new trial is now investigating remdesivir in combination with baricitinib or placebo as a treatment for COVID-19, in a double-blind, randomized trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE